Search for: "Novartis Pharmaceuticals Inc" Results 1 - 20 of 393
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
22 Jan 2024, 1:16 pm by Dennis Crouch
Novartis Pharmaceuticals Corporation (Amicus Curiae): Jane M. [read post]
11 Oct 2023, 1:23 am by Roel van Woudenberg
For all designated States except the US, it names Alexion Pharmaceuticals, Inc. and the University of Western Ontario as applicants. [read post]
28 Jul 2023, 11:46 am by Tom Lamb
Today we learned that soon after the July 2023 ASRS letter was sent out, a so-called "Dear Doctor" letter was sent to ophthalmologists by Apellis Pharmaceuticals, Inc., the drug company responsible for Syfovre. [read post]
19 Jul 2023, 10:30 am by Tom Lamb
We are investigating Syfovre drug injury lawsuits against Apellis Pharmaceuticals, Inc., the drug company responsible for Syfovre, for patients who developed occlusive retinal vasculitis, eye inflammation, vision loss, or blindness after receiving Syfovre injections. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
Similarly, Hacon HHJ stated in Teva v Novartis [2022] EWHC 2847 (Pat): “It seems that there was little or no interaction between Novartis’ three experts during the preparation of their evidence. [read post]
11 Nov 2022, 9:40 am by Holman
Novartis Pharmaceuticals Corp., Case No. 17-cv-04405-HSG, Document 565, July 22,2021 (N.D. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
9 Aug 2022, 5:53 pm by Dennis Crouch
Accord Healthcare, Inc., Docket No. 21-1070; petition from 38 F.4th 1013 (U.S. [read post]
., Ltd. and HEC Pharm USA Inc., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
23 Jun 2022, 12:57 pm by Linda C. Severin
In 2020, another pharmaceutical company, Novartis, paid $678 million for similar misconduct. [read post]
21 Jun 2022, 9:46 pm by Patent Docs
Noonan -- The Federal Circuit recently granted a panel rehearing and vacated a panel decision between these parties decided earlier this year (see Novartis Pharmaceuticals Corp. v. [read post]